• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁场延长纳米颗粒驻留时间以提高. 的根除效率。

Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of .

机构信息

Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei 100, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, No. 7, Chung-Shan South Road, Taipei 100, Taiwan.

出版信息

ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54316-54327. doi: 10.1021/acsami.0c13101. Epub 2020 Nov 25.

DOI:10.1021/acsami.0c13101
PMID:33236884
Abstract

infection is one of the leading causes of several gastroduodenal diseases, such as gastritis, peptic ulcer, and gastric cancer. In fact, eradication provides a preventive effect against the incidence of gastric cancer. Amoxicillin is a commonly used antibiotic for eradication. However, due to its easy degradation by gastric acid, it is necessary to administer it in a large dosage and to combine it with other antibiotics. This complexity and the strong side effects of eradication therapy often lead to treatment failure. In this study, the chitosan/poly (acrylic acid) particles co-loaded with superparamagnetic iron oxide nanoparticles and amoxicillin (SPIO/AMO@PAA/CHI) are used as drug nano-carriers for eradication therapy. and results show that the designed SPIO/AMO@PAA/CHI nanoparticles are biocompatible and could retain the biofilm inhibition and the bactericidal effect of amoxicillin against . Moreover, the mucoadhesive property of chitosan allows SPIO/AMO@PAA/CHI nanoparticles to adhere to the gastric mucus layer and rapidly pass through the mucus layer after exposure to a magnetic field. When PAA is added, it competes with amoxicillin for chitosan, so that amoxicillin is quickly and continuously released between the mucus layer and the gastric epithelium and directly acts on . Consequently, the use of this nano-carrier can extend the drug residence time in the stomach, reducing the drug dose and treatment period of eradication therapy.

摘要

感染是导致多种胃十二指肠疾病的主要原因之一,如胃炎、消化性溃疡和胃癌。事实上,根除幽门螺杆菌可预防胃癌的发生。阿莫西林是一种常用于根除幽门螺杆菌的抗生素。然而,由于其易被胃酸降解,因此需要大剂量使用,并与其他抗生素联合使用。这种复杂性和根除治疗的强烈副作用往往导致治疗失败。在本研究中,将载有超顺磁性氧化铁纳米颗粒和阿莫西林的壳聚糖/聚丙烯酸共聚物纳米粒子(SPIO/AMO@PAA/CHI)用作根除治疗的药物纳米载体。和结果表明,设计的 SPIO/AMO@PAA/CHI 纳米粒子具有生物相容性,可保留阿莫西林对的生物膜抑制和杀菌作用。此外,壳聚糖的粘液附着特性使 SPIO/AMO@PAA/CHI 纳米粒子在暴露于磁场后能够附着在胃粘液层上并迅速穿透粘液层。当添加 PAA 时,它会与阿莫西林竞争壳聚糖,从而使阿莫西林在粘液层和胃上皮细胞之间快速且持续释放,并直接作用于。因此,使用这种纳米载体可以延长药物在胃中的停留时间,减少根除治疗的药物剂量和治疗周期。

相似文献

1
Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of .磁场延长纳米颗粒驻留时间以提高. 的根除效率。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54316-54327. doi: 10.1021/acsami.0c13101. Epub 2020 Nov 25.
2
Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.基于脲基修饰壳聚糖衍生物的阿莫西林-UCCs-2/TPP 纳米粒的抗幽门螺杆菌效果和靶向递药性能。
Int J Biol Macromol. 2018 Aug;115:367-374. doi: 10.1016/j.ijbiomac.2018.04.070. Epub 2018 Apr 14.
3
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.用于根除幽门螺杆菌的基于美丽决明子的三水合阿莫西林漂浮型生物黏附胃滞留微丸。
Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28.
4
Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.胃部特异性抗幽门螺杆菌疗法:载阿莫西林壳聚糖黏膜黏附微球的制备与评价
Curr Drug Deliv. 2007 Jan;4(1):41-50. doi: 10.2174/156720107779314811.
5
Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.一种用于根除幽门螺杆菌的新型阿莫西林胃内漂浮原位凝胶系统的研发与评价
Int J Pharm. 2007 Apr 20;335(1-2):114-122. doi: 10.1016/j.ijpharm.2006.11.008. Epub 2006 Nov 6.
6
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.壳聚糖微/纳米颗粒在治疗胃部感染中的潜在效用。
Expert Rev Anti Infect Ther. 2014 Aug;12(8):981-92. doi: 10.1586/14787210.2014.930663. Epub 2014 Jun 30.
7
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.载药 pH 敏感水凝胶纳米粒用于根除幽门螺杆菌的阿莫西林递送
Biomacromolecules. 2010 Jan 11;11(1):133-42. doi: 10.1021/bm900985h.
8
Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.载阿莫西林的黏附性纳米颗粒在实验性沙鼠模型中的抗幽门螺杆菌作用
AAPS PharmSciTech. 2004 Apr 7;5(2):e32. doi: 10.1208/pt050232.
9
Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.金合欢素交联岩藻糖壳聚糖/肝素纳米粒根除幽门螺杆菌。
Biomaterials. 2013 Jun;34(18):4466-79. doi: 10.1016/j.biomaterials.2013.02.028. Epub 2013 Mar 15.
10
Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.载阿莫西林的卡波姆 934P 胃溶型黏附性微球的制备与评价及其抗幽门螺杆菌治疗。
J Microencapsul. 2009 Jun;26(4):365-76. doi: 10.1080/02652040802373012.

引用本文的文献

1
Chitosan-based formulations for therapeutic applications. A recent overview.用于治疗应用的基于壳聚糖的制剂。近期综述。
J Biomed Sci. 2025 Jul 8;32(1):62. doi: 10.1186/s12929-025-01161-7.
2
Targeted nanomedicines for the treatment of infection.用于治疗感染的靶向纳米药物。
Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.
3
Comparison of accumulation and distribution of PEGylated and CD-47-functionalized magnetic nanoporous silica nanoparticles in an in vivo mouse model of implant infection.
聚乙二醇化和CD-47功能化磁性纳米多孔二氧化硅纳米颗粒在植入性感染小鼠体内模型中的蓄积与分布比较。
PLoS One. 2025 May 2;20(5):e0321888. doi: 10.1371/journal.pone.0321888. eCollection 2025.
4
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.纳米材料:一种用于生物膜形成治疗的前瞻性策略。
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.
5
Novel Drug Delivery Systems for Combating : A Brief Review.用于对抗的新型药物递送系统:简要综述。
Arch Razi Inst. 2024 Oct 31;79(5):903-914. doi: 10.32592/ARI.2024.79.5.903. eCollection 2024 Oct.
6
Single-dose oral administration of drug-loaded magnetic 3D-printed microbullets for eradication of .单剂量口服载药磁性3D打印微丸用于根除……
Asian J Pharm Sci. 2025 Apr;20(2):101013. doi: 10.1016/j.ajps.2024.101013. Epub 2025 Jan 3.
7
Research trends of nanomaterials in : a bibliometric analysis from 2003 to 2023.纳米材料在……方面的研究趋势:2003年至2023年的文献计量分析
Front Pharmacol. 2025 Mar 28;16:1546395. doi: 10.3389/fphar.2025.1546395. eCollection 2025.
8
Molecular Mechanisms of Biofilm Formation in .. 中生物膜形成的分子机制
Antibiotics (Basel). 2024 Oct 16;13(10):976. doi: 10.3390/antibiotics13100976.
9
Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics.认识胃肠道的生物学屏障和病理生理学特征,用于设计和应用纳米药物。
Drug Deliv. 2024 Dec;31(1):2415580. doi: 10.1080/10717544.2024.2415580. Epub 2024 Oct 15.
10
Multiple biological characteristics and functions of intestinal biofilm extracellular polymers: friend or foe?肠道生物膜胞外聚合物的多种生物学特性与功能:益友还是劲敌?
Front Microbiol. 2024 Aug 19;15:1445630. doi: 10.3389/fmicb.2024.1445630. eCollection 2024.